CRISPR Enables In Vivo CAR T Cell Production - Top-Institutions - MDSpire

CRISPR Enables In Vivo CAR T Cell Production

In vivo gene editing strategy generates CAR T cells directly inside the body – sidestepping costly manufacturing

  • March 30, 2026

  • 2 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Immunotherapy
    • Gene Editing
    • Hematology-Oncology

  • #2

    Massachusetts Institute of Technology (MIT) - Koch Institute
    Massachusetts Institute of Technology (MIT) - Koch Institute

    Cambridge, MA

    Key Differentiators

    • Gene Editing
    • Synthetic Biology
    • Cancer Immunotherapy

  • #3

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Immunotherapy
    • Gene Therapy
    • Hematology-Oncology

  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Cancer Immunotherapy
    • Gene Editing
    • Hematologic Malignancies

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Gene Therapy
    • Immunotherapy
    • CRISPR Technology

Original Source(s)

CRISPR Enables In Vivo CAR T Cell Production

  • March 30, 2026

Related Content

Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”